Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NRIX | AMGN | VRTX | REGN | BMY |
| Company | Nurix Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 13.69 | 312.15 | 425.99 | 980.00 | 44.88 |
| High | 13.98 | 312.15 | 430.52 | 982.58 | 45.31 |
| Low | 13.55 | 307.06 | 424.56 | 970.99 | 44.83 |
| Last | 13.94 | 308.45 | 429.93 | 976.96 | 45.06 |
| Change | +0.43 | -1.70 | +7.15 | +3.16 | +0.12 |
| % Change | +3.18% | -0.55% | +1.69% | +0.32% | +0.27% |
| Volume | 326,700 | 1,558,400 | 939,700 | 284,300 | 12,642,400 |
| 20-Day Average Volume | 905,695 | 2,921,775 | 1,086,080 | 473,155 | 14,203,315 |
| Previous Close | 13.51 | 310.15 | 422.78 | 973.80 | 44.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.44 | 283.76 | 403.57 | 922.92 | 45.83 |
| 20-Day Raw Stochastic | 58.29% | 77.15% | 98.51% | 94.77% | 27.73% |
| 20-Day Relative Strength | 52.20% | 64.65% | 66.07% | 62.03% | 37.63% |
| Weighted Alpha | +21.06 | +36.38 | +26.92 | +29.87 | -32.13 |
| Today's Opinion | 56% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 40% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 100% Buy | 40% Sell | 24% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.45% since 05/06/24 | +3.00% since 05/06/24 | +6.81% since 05/06/24 | +1.91% since 05/06/24 | +2.64% since 05/06/24 |
| Low | 13.18 on 05/07/24 | 298.51 on 05/07/24 | 394.03 on 05/07/24 | 952.14 on 05/08/24 | 43.49 on 05/09/24 |
| High | 14.52 on 05/09/24 | 314.89 on 05/10/24 | 430.52 on 05/13/24 | 982.58 on 05/13/24 | 45.31 on 05/13/24 |
| 1-Month | |||||
| %Chg | -16.73% since 04/12/24 | +15.40% since 04/12/24 | +8.42% since 04/12/24 | +7.99% since 04/12/24 | -6.67% since 04/12/24 |
| Low | 11.90 on 04/30/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 16.71 on 04/15/24 | 322.60 on 05/03/24 | 430.52 on 05/13/24 | 982.58 on 05/13/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +59.86% since 02/13/24 | +6.19% since 02/13/24 | +3.34% since 02/13/24 | +3.88% since 02/13/24 | -7.49% since 02/13/24 |
| Low | 8.84 on 02/14/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 18.12 on 04/11/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +165.02% since 11/13/23 | +15.66% since 11/13/23 | +13.46% since 11/13/23 | +22.63% since 11/13/23 | -10.15% since 11/13/23 |
| Low | 5.65 on 11/27/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 784.96 on 11/15/23 | 43.33 on 05/02/24 |
| High | 18.12 on 04/11/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 685,165 | 165,463,376 | 110,944,728 | 107,647,312 | 91,341,128 |
| Shares Outstanding, K | 49,151 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 76,990,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -143,950,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 16,590,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -41,520,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 2.10 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.76 on 04/10/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 04/11/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.65 | 28.07 | 26.24 | 42.80 |